Valproate sodium and Schizoaffective disorder - a phase IV clinical study of FDA data
Summary:
Schizoaffective disorder is reported as a side effect among people who take Valproate sodium (valproate sodium), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Olanzapine, and have Schizophrenia.
The phase IV clinical study analyzes which people have Schizoaffective disorder when taking Valproate sodium. It is created by eHealthMe based on reports of 23,476 people who have side effects when taking Valproate sodium from the FDA, and is updated regularly.
What is Valproate sodium?
Valproate sodium has active ingredients of valproate sodium. It is often used in epilepsy. eHealthMe is studying from 24,044 Valproate sodium users. Check the latest studies of Valproate sodium.
What is Schizoaffective disorder?
Schizoaffective disorder (a mental disorder characterized by disordered thought) is found to be associated with 268 drugs and 300 conditions by eHealthMe. Check the latest studies of Schizoaffective disorder.
23,476 people reported to have side effects when taking Valproate sodium.
Among them, 128 people (0.55%) have Schizoaffective disorder.
Among these 128 people:
How long have people been on Valproate sodium when they have Schizoaffective disorder? *
What is the gender of people who have Schizoaffective disorder when taking Valproate sodium? *
What is the age of people who have Schizoaffective disorder when taking Valproate sodium? *
What are other drugs people take besides Valproate sodium? *
What are other side effects people have besides Schizoaffective disorder? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Valproate sodium and have Schizoaffective disorder?
- Check whether Schizoaffective disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Valproate sodium:
- Valproate sodium (24,044 reports)
Schizoaffective disorder treatments and more:
- Schizoaffective disorder (20,122 reports)
How severe was Schizoaffective disorder and when was it recovered:
Expand to all the drugs that have ingredients of valproate sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Valproate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Schizoaffective disorder:
- Schizoaffective disorder (268 drugs)
Browse all the conditions that are associated with Schizoaffective disorder:
- Schizoaffective disorder (300 conditions)
Related publications that referenced our studies
- Ayano G, "Bipolar Disorders and Valproate: Pharmacokinetics, Pharmacodynamics and Therapeutic Effects and Indications of Valproate: Review of Articles", Bipolar Disord, 2017 Jan .
- Bansal S, Gupta SK, "Sodium Valproate induced priapism in an adult with bipolar affective disorder", Indian journal of pharmacology, 2013 Jan .
- Ayano G, "Bipolar Disorders and Valproate: Pharmacokinetics, Pharmacodynamics and Therapeutic Effects and Indications of Valproate: Review of Articles", Bipolar Disord, 2017 Jan .
- Bansal S, Gupta SK, "Sodium Valproate induced priapism in an adult with bipolar affective disorder", Indian journal of pharmacology, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on valproate sodium (the active ingredients of Valproate sodium) and Valproate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Tapazole and Sandostatin Lar - 2 seconds ago
- Drug interactions of Irbesartan and Armodafinil - 5 seconds ago
- Drug interactions of Acyclovir and Q10 - 8 seconds ago
- Drug interactions of Isoniazid and Lotrisone - 12 seconds ago
- Could Glucosamine cause Leukocytosis? - 14 seconds ago
- Could Ciprofloxacin cause Uveitis? - 19 seconds ago
- Could Eliquis cause Vein Disorder? - 22 seconds ago
- Pitavastatin vs. Carvedilol, side effect and effectiveness comparison - 30 seconds ago
- Drug interactions of Hydroxyzine and Pulmozyme - 35 seconds ago
- Drug interactions of Cimetidine and Depakote - 37 seconds ago